Surgical Quality Improvement

Transurethral Resection of the Prostate (TURP) Outcomes

January 1, 2020 – December 31, 2020

The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s transurethral resection of the prostate (TURP) ACS NSQIP performance benchmarked against 435 participating sites.

Transurethral Resection of the Prostate (TURP) (435 sites)NObservedExpected
30 Day Morbidity675.97%4.33%
Cardiac671.49%0.12%
Urinary Tract Infection (UTI)672.99%3.31%
Return to Operating Room (ROR)670.00%1.40%
Readmission672.99%4.53%

American College of Surgeons National Surgical Quality Improvement Program, 2021.
ACS NSQIP® Semiannual Report July 8, 2021, Chicago: American College of Surgeons.